The National Medical Products Administration (NMPA) has granted marketing approval to Rapid Medical Ltd for its intracranial thrombectomy stent. This medical device, which comprises a head end, wire mesh, push shaft, control wire, and handle, is equipped with controllable expansion technology that enhances its utility in surgical procedures.
Enhanced Surgical Precision with Controllable Expansion Technology
During the surgical process, medical professionals can manipulate the degree of expansion of the stent and the radial force exerted on blood vessels and thrombi in real-time. This feature ensures the safe and precise delivery of the device to the affected area, significantly improving the precision of the thrombus release process and increasing the success rate of thrombus removal. The controllable expansion technology allows doctors to finely adjust the stent, providing greater control over the procedure and reducing the risk of complications.
Reduced Disturbance and Vessel Damage During Retraction
Upon retracting the stent, physicians can moderately contract it to decrease the radial force, thereby minimizing disturbance and damage to sensitive and fragile blood vessel walls. This innovative design contributes to the safety and efficacy of the thrombectomy procedure, offering a valuable tool in the treatment of intracranial vascular diseases.-Fineline Info & Tech
